Vaxart Inc. Insider Trading

VXRT

⊜ Compare

Last 12 months

Insiders bought 31K on the open market and sold nothing.

Net open-market

+31K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

May 2026

May 22, 2026

Get an email when VXRT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 22	W. Mark Watson Director	Bought	10,000	$0.65	7K	8.1%	Form 4
Nov 17, 2025	W. Mark Watson Director	Bought 2 parts	20,000	$0.41 average	8K	19%	Form 4
Nov 17, 2025	Elaine J Heron Director	Bought 2 parts	40,000	$0.40 average	16K	71%	Form 4
Jul 17, 2025 – Aug 15, 2025	Kevin Finney Director	Bought 6 parts	166,668	$0.37 average	62K	437%	Form 4
Jul 29, 2025	W. Mark Watson Director	Bought	10,000	$0.41	4K	11%	Form 4
May 19, 2025	Steven Lo President, Chief Exec Officer	Bought	100,000	$0.49	49K	New	Form 4

May 22
W. Mark Watson
Director · bought 10,000 at $0.65
7K
8.1% of stake
Nov 17, 2025
W. Mark Watson
Director · bought 20,000 at avg $0.41
8K
19% of stake
Nov 17, 2025
Elaine J Heron
Director · bought 40,000 at avg $0.40
16K
71% of stake
Jul 17, 2025 – Aug 15, 2025
Kevin Finney
Director · bought 166,668 at avg $0.37
62K
437% of stake
Jul 29, 2025
W. Mark Watson
Director · bought 10,000 at $0.41
4K
11% of stake
May 19, 2025
Steven Lo
President, Chief Exec Officer · bought 100,000 at $0.49
49K
New position

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VXRT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with VXRT

CompareIntrinsic value

VIRVir Biotechnology Inc.

$11.77+4.90%10

VCELVericel Corporation

$45.48+10.68%65

ADPTAdaptive Biotechnologies Corporation

$26.71+3.53%40

RGNXRegenxbio Inc.

$7.71+1.05%40

IBRXImmunityBio, Inc.

$8.45+1.87%30

IOVAIovance Biotherapeutics, Inc.

$8.70-1.47%10

BEAMBeam Therapeutics Inc.

$27.79+5.55%40

DNLIDenali Therapeutics Inc.

$20.81+6.97%10

Spot a number that looks wrong? Check it in VXRT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VXRT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.